Search

everythinglearnresearchcommunity

for

Search:↓

The document's conclusion cannot be provided because the content is not accessible or understandable.

The document concludes with the creation of a Hair Transplant Foundation after reviewing the early hair transplant techniques and discussions from a forum.

Most women with long-term, widespread hair loss need a tissue examination for an accurate diagnosis.

Older female squirrel monkeys often experience a type of hair loss similar to chronic telogen effluvium in humans.

Diagnosing diffuse alopecia, a hair loss condition, can be challenging and may require a scalp biopsy or tracking the disease's progression when symptoms and skin tests aren't enough.

Diagnosing hair loss disorders needs clinical, dermoscopic, and histological differences, and checking menstrual cycle, weight changes, drug therapy, and nail changes.

Routine thyroid tests for diffuse alopecia in women may not be necessary, but checking for iron deficiency anemia could be useful.

Women with certain types of hair loss may have low iron levels.

The conclusion is that examining the scalp closely and checking for iron levels and thyroid issues is key to understanding chronic hair loss in women.

Hair loss common in men and women, limited treatments available.

Aging alone rarely causes significant hair loss; hormones are a bigger factor.

Most women aged 20-40 in the study lost hair diffusely and in volume over 6 weeks to 6 months, mainly due to telogen effluvium, often without a clear cause.

TrichoScan effectively diagnoses different types of hair loss and is linked to low iron stores in patients.

The document concludes that hair loss is complex, affects many people, has limited treatments, and requires more research on its causes and psychological impact.

The conclusion is that acne, alopecia, and hyperhidrosis are common skin issues with various treatments available, and accurate diagnosis is key for effective management.

Hair loss can be caused by stress, infections, drugs, and various diseases, with treatment depending on accurate diagnosis.

The document explains different hair loss types and treatments, emphasizing diagnosis through examination and tests, and specific treatments for each condition.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

Most women in the study lost hair due to chronic shedding, with stress and nutrient deficiencies being common factors.

ATE is linked to FAA, and treatment depends on cause; minoxidil helps, finasteride may worsen.

Women with hair loss have higher heart disease risk and unhealthy cholesterol levels.

Female hair loss patients more likely to have dry eye and gland issues.

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

Women with scarring alopecia have a lower quality of life and more anxiety and depression than those with non-scarring alopecia.

Injections with 0.5% minoxidil effectively treat female hair loss, increasing hair density and thickness.

Treat hair loss in postmenopausal women with diet, avoiding certain drugs, and using medications like minoxidil or finasteride.

TrichoScan is reliable for counting and measuring hair density but may not accurately assess hair types in women with hair loss.

The treatment improved hair growth and thickness in patients with hair loss, even 10 months after therapy without additional products.

Women with androgenetic alopecia (hair loss) have normal prostate specific antigen levels but higher testosterone levels.

High aldosterone and free testosterone levels link to female hair loss; testing aldosterone may predict hypertension risk.